Loading...
The ACR has updated its 2012 guideline on managing gout. Each recommendation is rated as “strong” (supported by moderate- or high-certainty evidence) or “conditional” (benefits and risks are closely balanced, or only low-certainty evidence or no data are available).
Urate-lowering therapy (ULT) is strongly recommended for patients with two or more gout flares annually, or tophi, or gout-related radiographic damage.
ULT is conditionally recommended for patients who have had more than one flare but whose flares are infrequent (<2 annually).
ULT is not recommended routinely after a first gout flare but is conditionally recommended for a patient with a first flare i…